Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/06/20 11:43:08」(JST)

wiki en

Glucuronidation is the addition of glucuronic acid to a substrate. Glucuronidation is often involved in xenobiotic metabolism of substances such as drugs, pollutants, bilirubin, androgens, estrogens, mineralocorticoids, glucocorticoids, fatty acid derivatives, retinoids, and bile acids. These linkages involve glycosidic bonds.^[1]

Mechanism

Glucuronidation consists of transfer of the glucuronic acid component of UDP-glucuronic acid to a substrate by any of several types of UDP-glucuronosyltransferase.

UDP-glucuronic acid (glucuronic acid linked via a glycosidic bond to uridine diphosphate) is an intermediate in the process and is formed in the liver. One example is the N-glucuronidation of an aromatic amine, 4-aminobiphenyl, by UGT1A4 or UGT1A9 from human, rat, or mouse liver.^[2]

The substances resulting from glucuronidation are known as glucuronides (or glucuronosides) and are typically much more water-soluble than non-glucuronic acid-containing substance from which they were originally synthesised. The human body uses glucuronidation to make a large variety of substances more water-soluble, and, in this way, allow for their subsequent elimination from the body through urine or feces (via bile from the liver). Hormones may also be glucuronidated to allow for easier transport around the body. Pharmacologists have linked drugs to glucuronic acid to allow for more effective delivery of a broad range of substances. Sometimes toxic substances are also less toxic after glucuronidation.

The conjugation of xenobiotic molecules with hydrophilic molecular species such as glucuronic acid is known as phase II metabolism.

Sites

Glucuronidation occurs mainly in the liver, although the enzyme responsible for its catalysis, UDP-glucuronyltransferase, has been found in all major body organs (e.g., intestine, kidneys, brain, adrenal gland, spleen, and thymus).^[3]^[4]

General influencing factors

Various factors affect the rate of glucuronidation, in turn causing increased or decreased glucuronidation of various substances, in turn affecting their clearance. Generally, an increased rate of glucuronidation results in less effect of affected drugs or compounds, and vice versa.

Factor		Effect on glucuronidation^[5]	Main drugs or compounds affected^[5]
Age	Infant	↑	Chloramphenicol, morphine, paracetamol, bilirubin, steroids
Age	Elderly	↑ or unchanged	No change found for paracetamol, oxazepam, temazepam, or propranolol. Decreased clearance found for codeine-6-glucuronide, and decreased unbound clearance for oxazepam in the very elderly.
Gender	Females	↓	Clearance higher in males for paracetamol, oxazepam, temazepam, and propranolol. Possible additive role with CYP1A2 resulting in higher clozapine and olanzapine concentrations in females
Gender	Males	↑
Body habitus	Overweight	↑	Clearance of lorazepam, oxazepam, temazepam, and paracetamol likely the result of an increase in liver size and quantity of enzyme
Body habitus	Underweight/malnourished	↓	Chloramphenicol, paracetamol
Disease states	Fulminant hepatitis, cirrhosis	↓	Zidovudine, oxazepam, lamotrigine
	Hypothyroidism	↓	Oxazepam, paracetamol
	HIV	↓	Paracetamol
Tobacco smoking		↑	Propranolol, oxazepam, lorazepam, paracetamol. Possible additive role with CYP1A2 induction causing decreased clozapine and olanzapine concentration.

Affected drugs

Many drugs which are substrates for glucuronidation as part of their metabolism are significantly affected by inhibitors or inducers of their specific glucuronisyltransferase types:

Substrate	Inhibitors of glucuronidation^[5]	Inducers of glucuronidation,^[5]^[6]
Morphine	Amitriptyline Clomipramine Clonazepam Diazepam Flurnitrazepam Lorazepam Nitrazepam Oxazepam Codeine	Rifampin Tobacco smoking Phenobarbital
Oxazepam	Ethinylestradiol Fenoprofen Ibuprofen Ketoprofen Naproxen	Phenobarbitone Phenytoin
Bilirubin		Phenobarbital
Paracetamol	Ethinylestradiol Probenecid Propranolol
Androsterone	Promethazine Chlorpromazine
Carbamazepine- 10,1 1-transdiol	Valproic acid
Codeine	Amitriptyline Diclofenac
Lamotrigine	Sertraline Valproic acid
Lorazepam	Ethinylestradiol Probenecid Valproic acid
Temazepam	Probenecid
Testosterone	Amitriptyline Chlorpromazine Imipramine Promethazine
Zidovudine	Probenecid Valproic acid

References

^ King C, Rios G, Green M, Tephly T (2000). "UDP-glucuronosyltransferases". Curr. Drug Metab. 1 (2): 143–61. doi:10.2174/1389200003339171. PMID 11465080.
^ Al-Zoughool M., Talaska, G. (2006). "4-Aminobiphenyl N-glucuronidation by liver microsomes: optimization of the reaction conditions and characterization of the UDP-glucoronosyltransferase isoforms". J. Appl. Toxicology 26 (6): 524–532. doi:10.1002/jat.1172. PMID 17080401.
^ Ohno, Shuji; Nakajin, Shizuo (2008-10-06). "Determination of mRNA Expression of Human UDP-Glucuronosyltransferases and Application for Localization in Various Human Tissues by Real-Time Reverse Transcriptase-Polymerase Chain Reaction". Drug Metabolism and Disposition (American Society for Pharmacology and Experimental Therapeutics) 37 (1): 32–40. doi:10.1124/dmd.108.023598. Retrieved 2010-11-07.
^ Bock K, Köhle C (2005). "UDP-glucuronosyltransferase 1A6: structural, functional, and regulatory aspects". Methods enzymol. 400: 57–75. doi:10.1016/S0076-6879(05)00004-2. PMID 16399343.
^ ^a ^b ^c ^d Unless else specified in boxes, then reference is: Liston, H.; Markowitz, J.; Devane, C. (2001). "Drug glucuronidation in clinical psychopharmacology". Journal of Clinical Psychopharmacology 21 (5): 500–515. doi:10.1097/00004714-200110000-00008. PMID 11593076. edit
^ Neil B. Sandson, Drug-Drug Interaction Primer

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. ビリルビン過剰産生によるジルベール症候群および非抱合型ビリルビン過剰産生 gilbert syndrome and unconjugated hyperbilirubinemia due to bilirubin overproduction
2. 成人におけるアセトアミノフェン（パラセタモール）中毒：病態生理、症状、および診断 acetaminophen paracetamol poisoning in adults pathophysiology presentation and diagnosis
3. インテグラーゼ阻害剤の薬理学 pharmacology of integrase inhibitors
4. 第1世代抗精神病剤：薬理学、投与、および副作用の比較 first generation antipsychotic medications pharmacology administration and comparative side effects
5. 小児における非抱合型高ビリルビン血症による黄疸の評価 evaluation of jaundice caused by unconjugated hyperbilirubinemia in children

English Journal

Clinical pharmacology of paracetamol in neonates: a review.

Pacifici GM1, Allegaert K2.
Current therapeutic research, clinical and experimental.Curr Ther Res Clin Exp.2014 Dec 12;77:24-30. doi: 10.1016/j.curtheres.2014.12.001. eCollection 2015.
Paracetamol is commonly used to control mild-to-moderate pain or to reduce opioid exposure as part of multimodal analgesia, and is the only compound recommended to treat fever in neonates. Paracetamol clearance is lower in neonates than in children and adults. After metabolic conversion, paracetamol
PMID 25709719

Metabolites identification of bioactive licorice compounds in rats.

Wang Q1, Qian Y1, Wang Q1, Yang YF1, Ji S1, Song W1, Qiao X1, Guo DA1, Liang H2, Ye M3.
Journal of pharmaceutical and biomedical analysis.J Pharm Biomed Anal.2015 Nov 10;115:515-22. doi: 10.1016/j.jpba.2015.08.013. Epub 2015 Aug 17.
Licorice (Glycyrrhiza uralensis Fisch.) is one of the most popular herbal medicines worldwide. This study aims to identify the metabolites of seven representative bioactive licorice compounds in rats. These compounds include 22β-acetoxyl glycyrrhizin (1), licoflavonol (2), licoricidin (3), licoisof
PMID 26311472

An untargeted metabolomics-driven approach based on LC-TOF/MS and LC-MS/MS for the screening of xenobiotics and metabolites of Zhi-Zi-Da-Huang decoction in rat plasma.

Wu H1, Li X1, Yan X1, An L1, Luo K1, Shao M1, Jiang Y1, Xie R1, Feng F2.
Journal of pharmaceutical and biomedical analysis.J Pharm Biomed Anal.2015 Nov 10;115:315-22. doi: 10.1016/j.jpba.2015.07.026. Epub 2015 Jul 26.
Zhi-Zi-Da-Huang decoction (ZZDHD), a typical traditional Chinese medicine prescription, is widely used in clinical practice for the treatment of alcoholic liver disease. However, due to lack of holistic metabolic research, the active ingredients of ZZDHD have not been fully elucidated. It entails a
PMID 26275719

Japanese Journal

Effects of β-Naphthoflavone on Ugt1a6 and Ugt1a7 Expression in Rat Brain

Biological and Pharmaceutical Bulletin 39(1), 78-83, 2016
NAID 130005116501

UGT Xenobiotic metabolizing activity and genetic evolution in Pinniped species

Toxicological Sciences 147(2), 360-369, 2015-10
NAID 120005817898

Estimating the Differences of UGT1A1 Activity in Recombinant UGT1A1 Enzyme, Human Liver Microsomes and Rat Liver Microsome Incubation Systems <i>in Vitro</i>